Photo taken from Aleix Prat/X
May 19, 2024, 09:02
Aleix Prat: HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants
Aleix Prat, CoFounder of Reveal Genomics, shared a post on X:
“HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Led by Francesco Schettini, Matteo Lambertini.”
Read further.
Source: Aleix Prat/X